Browse studies

Find your next paid study

27,270 recruiting studies available now

A Prospective Long-Term Follow-Up Study to Evaluate the Use of the Minder Device to Aid in Treatment After Actionable Event Identification in Patients Diagnosed With Epilepsy.

The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not wel…

EpilepsyEpilepsy (Treatment Refractory)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Epiminder America, Inc.NCT07110454

Phase 2

Phase II Randomized Study of Fianlimab Plus Cemiplimab Versus Cemiplimab Plus Placebo in First-Line Treatment of Participants With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Is Positive for PD-L1 Expression

This study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab compared against cemiplima…

Head and Neck Squamous Cell Carcinoma (HNSCC)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT06769698

Phase 1

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients With Advanced or Metastatic Solid Tumors

This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find …

Advanced CancerMetastatic CancerOvarian Cancer+6 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Artios Pharma LtdNCT04657068

Observational

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

This study is to develop, test, and optimize a soft hip wearable robot for individuals with stroke, Parkinson's, multiple sclerosis, or older adults with no ne…

StrokeHealthy

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Shirley Ryan AbilityLabNCT07061691

Observational

Improving Glycemic Control With Electrical Stimulation in Mexican-Americans

Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subj…

ObesityOverweightInsulin Resistance

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas, El PasoNCT03947697

Observational

Multicenter National Parallel Cluster Randomized Controlled Superiority Trial Comparing an Artificial Intelligence-Based Screening Strategy to Usual Care for Improving Eye-Care Follow-Up Among Patients With Diabetes (AI-BRIDGE Trial)

This pragmatic clinical trial is being conducted to test the effectiveness of AI-BRIDGE (Artificial Intelligence-Based point of caRe, Incorporating Diagnosis, …

Diabetic RetinopathyDiabetes Mellitus

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Wisconsin, MadisonNCT06763952

Phase 1

A 2-part Phase 1/2 Open-label Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ODM-212 in Combination With Anti-cancer Therapy in Participants With Advanced Solid Tumours

An open-label, multi-site, multi-cohort phase 1/2 trial to be conducted in 2 parts (dose escalation and dose expansion/optimisation)

MesotheliomaPancreatic CancerNSCLC (Advanced Non-small Cell Lung Cancer)

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Orion Corporation, Orion PharmaNCT07563738

EXtubation Related Complications - an International Observational Study To Understand the Impact and BEst Practices in the Operating Room and Intensive Care Unit - the EXTUBE Study

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and …

Extubation

Estimated

~$10 – $750

Actual pay is set by the research site.

University Health Network, TorontoNCT06442930

Pacritinib Effectiveness in Real-world Settings (PACER)

This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a …

Myelofibrosis (MF)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Swedish Orphan BiovitrumNCT07774455

Observational

Surgical Drape With an Atraumatic Acrylic Adhesive for Negative Pressure Wound Therapy

Negative pressure wound therapy (NPWT) is widely used for chronic and acute wounds, severe burns, and post-operative care. Despite its benefits, the strong adh…

Frequency and Type of Medical Adhesive-Related Skin InjuryNPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate)Clinician Acceptability of New NPWT Drape+2 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Global Biomedical Technologies, LLCNCT06717308

Phase 2

A Phase 2, Randomized, Multicenter, Open-label, Blinded-endpoint Study to Evaluate the Safety of REGN7508 and REGN9933, Monoclonal Antibodies Against FXI, Versus Apixaban in Participants With Atrial Fibrillation (ROXI-ATLAS)

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that …

Atrial Fibrillation (AF)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT07175428

Phase 3

Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency

Background: Premature ovarian insufficiency (POI) is a condition in which women under the age of 40 years have absent or irregular menstrual cycles. POI can c…

Premature Ovarian Insufficiency

Estimated

~$50 – $1,350

Actual pay is set by the research site.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT06851754